Skip to main content
. Author manuscript; available in PMC: 2013 Sep 15.
Published in final edited form as: Clin Chem. 2009 Jun 11;55(8):1517–1522. doi: 10.1373/clinchem.2009.126664

Table 2.

Sensitivity of monoclonal gammopathy screening panels.

n All 5 tests Serum PEL and IFE; urine IFE Serum PEL, IFE, and FLC Serum PEL and FLC Serum IFE Serum PEL Serum FLC
Diagnosis, n
 All 1877 1851 1821 1828 1770 1632 1482 1395
 MM 467 467 461 467 467 441 409 452
 Macroglobulinemia 26 26 26 26 26 26 26 19
 SMM 191 191 191 191 190 188 180 155
 MGUS 524 524 524 509 465 486 429 222
 Plasmacytoma 29 26 26 26 25 21 21 16
 POEMS 31 30 30 30 23 30 23 3
 Extramedullary plasmacytoma 10 2 2 1 1 1 1 1
 Primary AL 581 570 547 564 559 429 383 513
 LCDD 18 15 14 14 14 10 10 14
Diagnosis, %
 All 98.6 97.0 97.4 94.3 87.0 79.0 74.3
 MM 100.0 98.7 100.0 100.0 94.4 87.6 96.8
 Macroglobulinemia 100.0 100.0 100.0 100.0 100.0 100.0 73.1
 SMM 100.0 100.0 100.0 99.5 98.4 94.2 81.2
 MGUS 100.0 100.0 97.1 88.7 92.8 81.9 42.4
 Plasmacytoma 89.7 89.7 89.7 86.2 72.4 72.4 55.2
 POEMS 96.8 96.8 96.8 74.2 96.8 74.2 9.7
 Extramedullary plasmacytoma 20.0 20.0 10.0 10.0 10.0 10.0 10.0
 Primary AL 98.1 94.2 97.1 96.2 73.8 65.9 88.3
 LCDD 83.3 77.8 77.8 77.8 55.6 55.6 77.8